BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 8996291)

  • 1. Coronary stent placement in patients with acute myocardial infarction: comparison of clinical and angiographic outcome after randomization to antiplatelet or anticoagulant therapy.
    Schömig A; Neumann FJ; Walter H; Schühlen H; Hadamitzky M; Zitzmann-Roth EM; Dirschinger J; Hausleiter J; Blasini R; Schmitt C; Alt E; Kastrati A
    J Am Coll Cardiol; 1997 Jan; 29(1):28-34. PubMed ID: 8996291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement: analysis of a prospective risk stratification protocol in the Intracoronary Stenting and Antithrombotic Regimen (ISAR) trial.
    Schühlen H; Hadamitzky M; Walter H; Ulm K; Schömig A
    Circulation; 1997 Apr; 95(8):2015-21. PubMed ID: 9133509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial.
    Kastrati A; Schühlen H; Hausleiter J; Walter H; Zitzmann-Roth E; Hadamitzky M; Elezi S; Ulm K; Dirschinger J; Neumann FJ; Schömig A
    Circulation; 1997 Jul; 96(2):462-7. PubMed ID: 9244213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained benefit over four years from an initial combined antiplatelet regimen after coronary stent placement in the ISAR trial. Intracoronary Stenting and Antithrombotic Regimen.
    Schühlen H; Kastrati A; Pache J; Dirschinger J; Schömig A
    Am J Cardiol; 2001 Feb; 87(4):397-400. PubMed ID: 11179521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.
    Schömig A; Neumann FJ; Kastrati A; Schühlen H; Blasini R; Hadamitzky M; Walter H; Zitzmann-Roth EM; Richardt G; Alt E; Schmitt C; Ulm K
    N Engl J Med; 1996 Apr; 334(17):1084-9. PubMed ID: 8598866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High pressure assisted coronary stent implantation accomplished without intravascular ultrasound guidance and subsequent anticoagulation.
    Nakamura S; Hall P; Gaglione A; Tiecco F; Di Maggio M; Maiello L; Martini G; Colombo A
    J Am Coll Cardiol; 1997 Jan; 29(1):21-7. PubMed ID: 8996290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet is superior to anticoagulant treatment after coronary stenting: fewer coronary and other events within 30 days after stenting.
    Foussas S; Alexopoulos D; Stefanadis C; Olympios C; Voudris V; Hatzimiltiadis S; Sionis D; Vavouranakis E; Vrahatis A; Fakiolas C; Pissimisis E; Stefanidis A; Zairis M; Pavlides G; Vitakis S; Louridas G; Cokkinos D; Toutouzas P
    Angiology; 2000 Apr; 51(4):289-94. PubMed ID: 10778998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance.
    Colombo A; Hall P; Nakamura S; Almagor Y; Maiello L; Martini G; Gaglione A; Goldberg SL; Tobis JM
    Circulation; 1995 Mar; 91(6):1676-88. PubMed ID: 7882474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary stent implantation without coumadin in acute myocardial infarction.
    Saito S; Hosokawa FG; Kim K; Tanaka S; Miyake S
    J Am Coll Cardiol; 1996 Jul; 28(1):74-81. PubMed ID: 8752797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wiktor stent for treatment of chronic total coronary artery occlusions: short- and long-term clinical and angiographic results from a large multicenter experience.
    Anzuini A; Rosanio S; Legrand V; Tocchi M; Coppi R; Bonnier H; Sheiban I; Kulbertus HE; Chierchia SL
    J Am Coll Cardiol; 1998 Feb; 31(2):281-8. PubMed ID: 9462568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
    Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
    Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study.
    Bertrand ME; Legrand V; Boland J; Fleck E; Bonnier J; Emmanuelson H; Vrolix M; Missault L; Chierchia S; Casaccia M; Niccoli L; Oto A; White C; Webb-Peploe M; Van Belle E; McFadden EP
    Circulation; 1998 Oct; 98(16):1597-603. PubMed ID: 9778323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Single-center experience with the Palmaz-Schatz intracoronary stent: the immediate results and medium- and long-term follow-up].
    Galassi AR; Tamburino C; Grassi R; Monaco A; Russo G; Ierna SM; Calvi V; Giuffrida G
    Cardiologia; 1996 Nov; 41(11):1097-105. PubMed ID: 9064207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of cilostazol versus ticlopidine hydrochloride for antiplatelet therapy after coronary stent implantation for prevention of late restenosis.
    Kamishirado H; Inoue T; Mizoguchi K; Uchida T; Nakata T; Sakuma M; Takayanagi K; Morooka S
    Am Heart J; 2002 Aug; 144(2):303-8. PubMed ID: 12177649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cilostazol versus ticlopidine therapy after stent implantation.
    Park SW; Lee CW; Kim HS; Lee HJ; Park HK; Hong MK; Kim JJ; Park SJ
    Am J Cardiol; 1999 Sep; 84(5):511-4. PubMed ID: 10482146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cilostazol on angiographic restenosis after coronary stent placement.
    Park SW; Lee CW; Kim HS; Lee NH; Nah DY; Hong MK; Kim JJ; Park SJ
    Am J Cardiol; 2000 Sep; 86(5):499-503. PubMed ID: 11009265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of cilostazol versus ticlopidine in coronary artery stenting.
    Yoon Y; Shim WH; Lee DH; Pyun WB; Kim IJ; Jang Y; Cho SY
    Am J Cardiol; 1999 Dec; 84(12):1375-80. PubMed ID: 10606107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two antiplatelet regimens (aspirin alone versus aspirin + ticlopidine or clopidogrel) after intracoronary implantation of a carbofilm-coated stent.
    Bartorelli AL; Tamburino C; Trabattoni D; Galassi A; Serdoz R; Sheiban I; Piovaccari G; Zimarino M; Benassi A; Di Mario C; Sangiorgio P; Chierchia S; Reimers B;
    Am J Cardiol; 2007 Apr; 99(8):1062-6. PubMed ID: 17437728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immediate and long-term clinical and angiographic results of the Wiktor stent in the treatment of chronic coronary occlusions].
    Anzuini A; Rosanio S; Legrand V; Tocchi M; Coppi R; Marazzi G; Vicedomini G; Pagnotta P; Montorfano M; Bonnier H; Sheiban I; Kulbertus HE; Chierchia SL
    G Ital Cardiol; 1997 Sep; 27(9):881-91. PubMed ID: 9378193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.
    Leon MB; Baim DS; Popma JJ; Gordon PC; Cutlip DE; Ho KK; Giambartolomei A; Diver DJ; Lasorda DM; Williams DO; Pocock SJ; Kuntz RE
    N Engl J Med; 1998 Dec; 339(23):1665-71. PubMed ID: 9834303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.